Ty Rorick was named Head of Research Operations in 2019. In this role, he leads all DCRI operations in support of clinical trials and studies, has leadership of the Operations Management Team, and oversees the DCRI’s operations improvement initiatives underway.
Previously, Rorick was Interim Director of the DCRI Industry Trials group. Before that, he spent 11 years in the DCRI MegaTrials group, rising from a project lead to an associate director; this followed 13 years with Procter & Gamble Pharmaceuticals.
Rorick’s work has spanned high-profile pivotal Phase III trials on behalf of the industry’s leading pharmaceutical companies, to Phase I and II trials that require precise execution and deadline adherence. Rorick believes that building responsive, meaningful relationships are paramount to successful trials. His network of collaborations extends to the major clinical and academic research organizations of the world, mid-size to start-up biopharmaceutical companies, and institutes like the Patient-Centered Outcomes Research Institute (PCORI). He is deeply respected in the industry for his knowledge and clinical research management experience.
Rorick holds a degree in business from the University of Cincinnati, and a nursing degree from Northern Kentucky University.